M&A Surge Hits Record $140 Billion Amid Novo Nordisk/Pfizer Dispute and OpenAI Restructuring

A surge in multibillion-dollar M&A transactions has pushed the year's total to over $140 billion in just seven days. Notable deals include Novo Nordisk's offer to acquire Metsera for at least $6.5 billion, Novartis' $12 billion deal for Avidity Biosciences, and OpenAI's restructuring plan granting Microsoft a 27% stake worth over $130 billion. These transactions highlight the enthusiasm for AI and the potential for massive tie-ups in the coming years.